Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
The Gabelli Healthcare & Wellness Trust | GRX | Sep 20, 2024 | 11.15 | +0.41 |
The Gdl Fund | GDL | Sep 20, 2024 | 8.06 | +0.12 |
The Glimpse Group | VRAR | Sep 20, 2024 | 0.77 | +0.05 |
The Hackett Group | HCKT | Sep 20, 2024 | 26.02 | -3.20 |
The Hain Celestial Group | HAIN | Sep 20, 2024 | 7.74 | -1.65 |
The Hershey | HSY | Sep 20, 2024 | 195.43 | -0.05 |
The Herzfeld Caribbean Basin Fund | CUBA | Sep 20, 2024 | 2.29 | 0.00 |
The Honest Company | HNST | Sep 20, 2024 | 3.70 | -0.80 |
The Intergroup | INTG | Sep 20, 2024 | 16.41 | +1.23 |
The J.M Smucker Company | SJM | Sep 20, 2024 | 118.74 | -0.47 |
The Joint | JYNT | Sep 20, 2024 | 11.41 | -4.12 |
The Marygold Companies | MGLD | Sep 20, 2024 | 1.54 | +18.46 |
The ODP | ODP | Sep 20, 2024 | 28.64 | -3.70 |
The OLB Group | OLB | Sep 20, 2024 | 2.56 | +17.43 |
The Oncology Institute | TOI | Sep 20, 2024 | 0.29 | -0.58 |
The ONE Group Hospitality | STKS | Sep 20, 2024 | 3.57 | -3.77 |
The Pennant Group | PNTG | Sep 20, 2024 | 35.68 | +0.20 |
The Real Brokerage | REAX | Sep 20, 2024 | 5.73 | -0.87 |
The Real Estate Select Sector SPDR Fund | XLRE | Sep 20, 2024 | 44.68 | -0.18 |
The RealReal | REAL | Sep 20, 2024 | 3.24 | -0.61 |
The RMR Group A | RMR | Sep 20, 2024 | 24.99 | -2.50 |
The Shyft Group | SHYF | Sep 20, 2024 | 12.66 | -3.65 |
The Trade Desk A | TTD | Sep 20, 2024 | 109.51 | -0.57 |
The9 ADR | NCTY | Sep 20, 2024 | 6.50 | -1.55 |
TherapeuticsMD | TXMD | Sep 20, 2024 | 1.71 | -0.58 |
Theratechnologies | THTX | Sep 20, 2024 | 1.24 | +1.64 |
Theravance Biopharma | TBPH | Sep 20, 2024 | 8.01 | -2.44 |
Theriva Biologics | TOVX | Sep 20, 2024 | 3.80 | +0.26 |
Thermo Fisher Scientific | TMO | Sep 20, 2024 | 613.69 | -1.06 |
Thermon Group | THR | Sep 20, 2024 | 29.99 | -2.47 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.